NMRA Insider Trading Activity and SEC Form 4 Filings
NMRA insider trading summary
Over the past 12 months, insiders at Neumora Therapeutics, Inc. (NMRA) reported 16 sales worth $1.1M by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $1.1M.
Latest NMRA insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 21, 2026 | Daljit Singh Aurora | See Remarks | Sell | $34K (21,055 @ $1.60) |
| Aug 21, 2026 | Daljit Singh Aurora | See Remarks | Sell | $33K (20,553 @ $1.59) |
| Aug 20, 2026 | Daljit Singh Aurora | See Remarks | Sell | $101K (66,711 @ $1.51) |
| Aug 20, 2026 | Daljit Singh Aurora | See Remarks | Sell | $103K (67,741 @ $1.51) |
| Aug 19, 2026 | Daljit Singh Aurora | See Remarks | Sell | $51K (30,918 @ $1.65) |
| Aug 19, 2026 | Daljit Singh Aurora | See Remarks | Sell | $51K (31,000 @ $1.65) |
| Aug 18, 2026 | Daljit Singh Aurora | See Remarks | Sell | $54K (34,162 @ $1.58) |
| Aug 18, 2026 | Daljit Singh Aurora | See Remarks | Sell | $55K (34,987 @ $1.59) |
| Aug 17, 2026 | Daljit Singh Aurora | See Remarks | Sell | $51K (34,020 @ $1.49) |
| Aug 17, 2026 | Daljit Singh Aurora | See Remarks | Sell | $83K (55,016 @ $1.50) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.